Dellora Investments Master Fund LP 13D and 13G filings for Pieris Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-06 2:21 pm Purchase | 2024-11-06 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Dellora Investments Master Fund LP | 141,079 10.700% | 32,105 (+29.46%) | Filing |
| 2024-08-07 2:16 pm Purchase | 2024-07-24 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Dellora Investments Master Fund LP | 108,974 8.300% | 108,974 (New Position) | Filing |